- Daiichi Sankyo Pharma Development is the product development arm of the U.S. organization, engaged in Clinical Development, Translational Medicine & Clinical Pharmacology, Regulatory Affairs & Risk Management, Informatics & Knowledge Management, Biostatistics and Data Operations and Development Research. We conduct clinical studies and expedite product registrations for the United States and Europe, and collaborate with our Tokyo parent company on all of our global product development projects as well.
We are led by a group of highly experienced pharmaceutical executives who have gained broad experience at some of the world's leading pharmaceutical companies. In addition, we have a significant number of senior staff from Japan to assist in and coordinate our global development activities. Along with our staff of about 200 employees, we utilize outsourcing strategies for additional functional support. One such example is our partnership with MDS Pharma Services to establish the company's first collaborative clinical pharmacology unit. The unit is located in New Jersey and focuses on the evaluation of novel treatments for diabetes and lipid disorders.
The parent companies in Tokyo recognize that the U.S. and European markets are vital to their global success, and Daiichi Sankyo Pharma Development plays a key role in bringing innovative products to those markets.
|
- > Postal address
399 Thornall Street
Edison, NJ 08837
|
